Idexx Laboratories
IDXX
846 hedge funds and large institutions have $28.8B invested in Idexx Laboratories in 2020 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 281 increasing their positions, 306 reducing their positions, and 51 closing their positions.
94% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 51
16% more capital invested
Capital invested by funds: $24.8B → $28.8B (+$4.06B)
9% more funds holding in top 10
Funds holding in top 10: 22 → 24 (+2)
6% more funds holding
Funds holding: 801 → 846 (+45)
4% less call options, than puts
Call options by funds: $63.1M | Put options by funds: $65.7M
8% less repeat investments, than reductions
Existing positions increased: 281 | Existing positions reduced: 306
1.94% less ownership
Funds ownership: 88.3% → 86.37% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$115M |
| 2 |
BlackRock
New York
|
+$95.5M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$64.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$64.3M |
| 5 |
N
Natixis
Paris,
France
|
+$46.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$217M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$181M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$98.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$88.4M |
| 5 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$83.2M |
IDXX Hedge Fund Activity: Q3 2020 in Review
846 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2020, worth a combined $28.8B — up 16% from $24.8B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new IDXX positions and 51 closed out — a net gain of 48 holders — while 281 added to existing stakes and 306 trimmed.
The largest buyer was CIBC Private Wealth Group, adding an estimated $115M. The largest seller was Fidelity Investments, cutting an estimated $217M.
- 846 institutional investors held Idexx Laboratories (IDXX) as of Q3 2020, up from 801 in Q2 2020.
- Funds reported $28.8B of Idexx Laboratories stock for Q3 2020, up 16% quarter-over-quarter.
- 99 funds opened new Idexx Laboratories positions in Q3 2020 and 51 closed out, a net change of +48 holders.
- The largest Idexx Laboratories buyer in Q3 2020 was CIBC Private Wealth Group, an estimated $115M added.
- The largest Idexx Laboratories seller in Q3 2020 was Fidelity Investments, an estimated $217M sold.
Based on aggregated 13F filings for Q3 2020.